Microtubule‐associated serine/threonine kinase (MAST)

Microtubule-associated serine/threonine (MAST) kinases are evolutionarily conserved modular proteins in the AGC protein kinase superfamily, characterized by: an N-terminal DUF1908 domain; a central serine/threonine kinase domain; and a C-terminal PDZ domain. MAST has four isoforms (MAST1-4) in mammals, which are widely expressed in tissues such as brain, heart, and liver[1].
MAST kinases can phosphorylate multiple substrates: MAST2 phosphorylates PTEN (reducing its activity/stability, interacting through the PDZ domain), NHE3 (inhibiting ion transport), and TRAF6 (regulating NF-κB signaling); MAST3 phosphorylates ARPP-16 (serine 46, inhibiting PP2A activity in striatal neurons); MAST4 phosphorylates Sox9 (serine 494, targeting proteasomal degradation) and ERM (serine 367, enhancing transcription). Among them, MAST1 can interact with proteins such as β2-syntrophin (linking the dystrophin complex and microtubules), and MAST2 with PCLKC (tumor suppressor) or/and 14-3-3 (phosphorylation-dependent interaction)[1].
Mechanistically, their domains enable substrate recognition (e.g., PDZ domain binding to C-terminal motif) and regulatory input (e.g., dimerization via PDZ domain). MAST kinases participate in pathways such as PI3K/mTOR (MAST4-PTEN axis in myeloma), ERK/MAPK (MAST1-cRaf/MEK complex in cisplatin resistance), and NF-κB (MAST2 inhibits TRAF6-dependent activation, MAST3 enhances TLR4-dependent activation in IBD)[1].
MAST kinases are closely associated with human diseases, including: cancer (MAST1/2 fusion/overexpression in breast/liver cancer, MAST4 in myeloma), neuronal diseases (rabies virus disrupts MAST2-PTEN interaction, MAST1 mutations lead to intellectual disability), cystic fibrosis (MAST2 regulates CFTR surface levels), male infertility (MAST2 duplication in azoospermia, MAST4 in spermatogonial stem cells), and inflammation (MAST3 in inflammatory bowel disease, MAST2 in LPS-induced inflammatory response). The modular structure and diverse interactions of MAST kinases make them key targets for understanding disease mechanisms[1].

By Effects: Inhibitor (2)
共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MAST2 Human Pre-designed siRNA Set A

MAST2 Human Pre-designed siRNA Set A 包含针对 MAST2(Human)基因不同区域设计的三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。

Inhibitor
MAST2 Human Pre-designed siRNA Set A
ST045945

WAY-230563 (ST045945) 是一种丝氨酸/苏氨酸激酶抑制剂,可通过阻断 CHK1/CHK2 介导的细胞周期检查点,诱导肿瘤细胞发生 G2/M 期阻滞和 DNA 损伤。

93326-70-6
Inhibitor
ST045945

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础